Nyarai D. Soko

Hypothesis: Do miRNAs Targeting the Leucine-Rich Repeat Kinase 2 Gene ( <i>LRRK2</i> ) Influence Parkinson's Disease Susceptibility?

Şenay Görücü Yılmaz, Sırma Geyik, Ayşe Münife Neyal et al. · OMICS A Journal of Integrative Biology · 2016 · 24 citations

Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes

Sarudzai Muyambo, Arinao Ndadza, Nyarai D. Soko et al. · OMICS A Journal of Integrative Biology · 2021 · 22 citations · Full text

An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T&gt;C and ABCG2 c.421A&gt;C

Nyarai D. Soko, Emile R. Chimusa, Collen Masimirembwa et al. · The Pharmacogenomics Journal · 2018 · 16 citations

Molecular Pharmacology, Rosuvastatin Plasma Variability, Slco1b1 C.521t +8

Differences in Genetic Variants in Lopinavir Disposition Among Hiv-Infected Bantu Africans

Bafokeng Mpeta, Elizabeth Kampira, Sandra Castel et al. · Pharmacogenomics · 2016 · 14 citations

Pharmacogenomics of Hypertension in Africa: Paving the Way for a Pharmacogenetic-Based Approach for the Treatment of Hypertension in Africans

Jonathan N. Katsukunya, Nyarai D. Soko, J Naidoo et al. · International Journal of Hypertension · 2023 · 12 citations · Full text